Brief: Genevant Sciences And Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
03/03/2025 14:48
March 3 (Reuters) - Arbutus Biopharma Corp ABUS.O: GENEVANT SCIENCES AND ARBUTUS BIOPHARMA INITIATE INTERNATIONAL PATENT INFRINGEMENT ENFORCEMENT ACTIONS AGAINST MODERNA GENEVANT: SEEKING MONETARY RELIEF, INJUNCTIONS AGAINST SPIKEVAX &, WHERE APPLICABLE, ADDITIONAL PRODUCTS THAT MODERNA REPRESENTED USE SAME LNP TECH Source text: ID:nGNXc8Pw7W Further company coverage: ABUS.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare